InflaRx NV (IFRX)
2.12
+0.03
(+1.44%)
USD |
NASDAQ |
Sep 21, 16:00
2.12
0.00 (0.00%)
After-Hours: 20:00
InflaRx Total Return Price : 2.12 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.09 |
| September 17, 2026 | 2.06 |
| September 16, 2026 | 2.04 |
| September 15, 2026 | 2.02 |
| September 14, 2026 | 2.12 |
| September 11, 2026 | 2.09 |
| September 10, 2026 | 2.05 |
| September 09, 2026 | 2.09 |
| September 08, 2026 | 2.17 |
| September 04, 2026 | 2.22 |
| September 03, 2026 | 2.23 |
| September 02, 2026 | 2.29 |
| September 01, 2026 | 2.16 |
| August 31, 2026 | 2.13 |
| August 28, 2026 | 2.23 |
| August 27, 2026 | 2.27 |
| August 26, 2026 | 2.42 |
| August 25, 2026 | 2.46 |
| August 24, 2026 | 2.05 |
| August 21, 2026 | 2.10 |
| August 20, 2026 | 2.02 |
| August 19, 2026 | 2.12 |
| August 18, 2026 | 2.18 |
| August 17, 2026 | 2.07 |
| August 14, 2026 | 2.04 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.01 |
| August 12, 2026 | 2.01 |
| August 11, 2026 | 2.00 |
| August 10, 2026 | 1.96 |
| August 07, 2026 | 1.84 |
| August 06, 2026 | 1.72 |
| August 05, 2026 | 1.77 |
| August 04, 2026 | 1.78 |
| August 03, 2026 | 1.75 |
| July 31, 2026 | 1.70 |
| July 30, 2026 | 1.72 |
| July 29, 2026 | 1.65 |
| July 28, 2026 | 1.69 |
| July 27, 2026 | 1.70 |
| July 24, 2026 | 1.74 |
| July 23, 2026 | 1.73 |
| July 22, 2026 | 1.80 |
| July 21, 2026 | 1.81 |
| July 20, 2026 | 1.82 |
| July 17, 2026 | 1.855 |
| July 16, 2026 | 1.91 |
| July 15, 2026 | 2.02 |
| July 14, 2026 | 2.01 |
| July 13, 2026 | 2.06 |
| July 10, 2026 | 2.05 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| MediGene AG | 0.10 |
| BioNTech SE | 98.02 |
| Immatics NV | 8.71 |
| Beam Therapeutics, Inc. | 25.26 |
| Kymera Therapeutics, Inc. | 117.72 |